Temporal evolution of metastatic disease: part I—an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors on …

N Jo, L Marcal, VS Katabathina, AC Morani… - Japanese Journal of …, 2021 - Springer
With improved survival rates of patients with metastatic disease due to continuously evolving
multimodality treatment options, radiologists are increasingly interpreting imaging studies …

Temporal evolution of metastatic disease: part I—an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors on …

N Jo, L Marcal, VS Katabathina… - Japanese Journal …, 2021 - scholars.uthscsa.edu
With improved survival rates of patients with metastatic disease due to continuously evolving
multimodality treatment options, radiologists are increasingly interpreting imaging studies …

Temporal evolution of metastatic disease: part I-an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors on serial …

N Jo, L Marcal, VS Katabathina… - … journal of radiology, 2021 - pubmed.ncbi.nlm.nih.gov
With improved survival rates of patients with metastatic disease due to continuously evolving
multimodality treatment options, radiologists are increasingly interpreting imaging studies …

Temporal evolution of metastatic disease: part I—an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors on …

N Jo, L Marcal, VS Katabathina… - Japanese …, 2021 - mdanderson.elsevierpure.com
With improved survival rates of patients with metastatic disease due to continuously evolving
multimodality treatment options, radiologists are increasingly interpreting imaging studies …

Temporal evolution of metastatic disease: part I-an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors on serial …

N Jo, L Marcal, VS Katabathina, AC Morani… - Japanese Journal of …, 2021 - europepmc.org
With improved survival rates of patients with metastatic disease due to continuously evolving
multimodality treatment options, radiologists are increasingly interpreting imaging studies …

[PDF][PDF] Temporal evolution of metastatic disease: part I—an in‑depth review of the evolution of metastatic disease across diverse spectrum of non‑neural solid tumors …

N Jo, L Marcal, VS Katabathina… - Japanese Journal of …, 2021 - researchgate.net
With improved survival rates of patients with metastatic disease due to continuously evolving
multimodality treatment options, radiologists are increasingly interpreting imaging studies …

Temporal evolution of metastatic disease: part I—an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors on …

J Nahyun, M Leonardo, KV Subbiah… - Japanese Journal …, 2021 - search.proquest.com
With improved survival rates of patients with metastatic disease due to continuously evolving
multimodality treatment options, radiologists are increasingly interpreting imaging studies …

[引用][C] Temporal evolution of metastatic disease: part I—an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors …

N Jo, L Marcal, VS Katabathina, AC Morani… - Japanese Journal of …, 2021 - cir.nii.ac.jp
Temporal evolution of metastatic disease: part I—an in-depth review of the evolution of
metastatic disease across diverse spectrum of non-neural solid tumors on serial oncologic …